Anupam Rasayan India Limited (ANURAS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Anupam Rasayan India Limited (ANURAS) has a cash flow conversion efficiency ratio of 0.015x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs396.98 Million ≈ $4.29 Million USD) by net assets (Rs25.91 Billion ≈ $280.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Anupam Rasayan India Limited - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Anupam Rasayan India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Anupam Rasayan India Limited (ANURAS) financial obligations for a breakdown of total debt and financial obligations.
Anupam Rasayan India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Anupam Rasayan India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Almonty Industries Inc. Common Shares
NASDAQ:ALM
|
0.063x |
|
Cosmo Pharmaceuticals N.V
F:C43
|
0.013x |
|
Eco World Develop Group
KLSE:8206
|
0.031x |
|
PT Arkora Hydro Tbk
JK:ARKO
|
-0.153x |
|
Greif Bros Corporation
NYSE:GEF
|
-0.008x |
|
PLUXEE NV
PA:PLX
|
0.434x |
|
JiangXi Tianxin Pharm Co Ltd
SHG:603235
|
N/A |
|
Global Partners LP
NYSE:GLP
|
0.028x |
Annual Cash Flow Conversion Efficiency for Anupam Rasayan India Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Anupam Rasayan India Limited from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Anupam Rasayan India Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs30.82 Billion ≈ $333.27 Million |
Rs-301.25 Million ≈ $-3.26 Million |
-0.010x | -148.53% |
| 2024-03-31 | Rs29.31 Billion ≈ $316.94 Million |
Rs590.32 Million ≈ $6.38 Million |
0.020x | -82.70% |
| 2023-03-31 | Rs25.08 Billion ≈ $271.24 Million |
Rs2.92 Billion ≈ $31.59 Million |
0.116x | +217.44% |
| 2022-03-31 | Rs17.27 Billion ≈ $186.75 Million |
Rs-1.71 Billion ≈ $-18.52 Million |
-0.099x | -10793.00% |
| 2021-03-31 | Rs15.73 Billion ≈ $170.16 Million |
Rs14.59 Million ≈ $157.79K |
0.001x | -99.42% |
| 2020-03-31 | Rs5.94 Billion ≈ $64.21 Million |
Rs949.43 Million ≈ $10.27 Million |
0.160x | +108.36% |
| 2019-03-31 | Rs5.07 Billion ≈ $54.84 Million |
Rs389.20 Million ≈ $4.21 Million |
0.077x | +273.35% |
| 2018-03-31 | Rs4.58 Billion ≈ $49.49 Million |
Rs-202.61 Million ≈ $-2.19 Million |
-0.044x | -164.80% |
| 2017-03-31 | Rs2.50 Billion ≈ $27.00 Million |
Rs170.57 Million ≈ $1.84 Million |
0.068x | -- |
About Anupam Rasayan India Limited
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients … Read more